Latest Articles

Publication Date
All News Scientific
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com

Published: March 5, 2025, 11:04 a.m.
Read Full Article
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today

ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today

Published: Feb. 5, 2025, 7:31 p.m.
Read Full Article
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today

Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Read Full Article
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Read Full Article
Dr Hinchcliff on the Addition of Dostarlimab to Chemotherapy in Advanced/Recurrent Endometrial Cancer - OncLive

Dr Hinchcliff on the Addition of Dostarlimab to Chemotherapy in Advanced/Recurrent Endometrial Cancer OncLive

Published: Jan. 27, 2025, 8:21 p.m.
Read Full Article
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post

European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post

Published: Jan. 21, 2025, 4:36 a.m.
Read Full Article
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - «Кавказ Пост» - новости Северного Кавказа и Закавказья

Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer «Кавказ Пост» - новости Северного Кавказа и Закавказья

Published: Jan. 12, 2025, 2:45 a.m.
Read Full Article
Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature - Cureus

Multiple Subcutaneous Metastases in Endometrial Cancer Treated With Systemic Chemotherapy: A Case Report and Review of the Literature Cureus

Published: Jan. 5, 2025, 6:05 a.m.
Read Full Article
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
Read Full Article
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today

Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today

Published: Dec. 18, 2024, 3:27 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!